Utilizing Nanobody Technology to Target Non-Immunodominant Domains of VAR2CSA


“Utilizing Nanobody Technology to Target Non-Immunodominant Domains of VAR2CSA” by using the ExpreS2 technology platform: PLoS One. 2014; 9(1): e84981. PMCID: PMC3897377

Read the article